Form 13-F position report

ENVERIC BIOSCIENCES INC

Reported by MORGAN STANLEY

ENVB CUSIP 29405E109 Manager CIK 0000895421

Reported 2 shares, up 1 (100.0%) from the prior quarter.

Added
% of reported 13F value 0 This manager · Q4 2021
Shares 2 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2022-03-31 0
2022-06-30 0
2022-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for ENVERIC BIOSCIENCES INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2022 Reduced 0 -1 (-100.0%) 0 $0 2022-11-14
Q2 2022 Unchanged 1 0 (0.0%) 0 $0 2022-08-15
Q1 2022 Reduced 1 -1 (-50.0%) 0 $0 2022-05-13
Q4 2021 Added 2 +1 (100.0%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

34 managers reported ENVERIC BIOSCIENCES INC for Q4 2021.

Managers reporting ENVERIC BIOSCIENCES INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 760,589 +264,936 < 0.01% $707,000 5 qtrs
PURA VIDA INVESTMENTS LLC New 742,046 +742,046 0.02% $690,000 1 qtr
RENAISSANCE TECHNOLOGIES LLC Added 554,100 +61,547 < 0.01% $515,000 2 qtrs
BlackRock Inc Added 501,378 +1,300 < 0.01% $466,000 4 qtrs
Ikarian Capital LLC New 400,000 +400,000 0.06% $372,000 1 qtr
Mirae Asset Global Investments Co Ltd New 392,920 +392,920 < 0.01% $365,000 1 qtr
AdvisorShares Investments LLC Added 300,524 +264,770 0.03% $279,000 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 166,537 +51,275 < 0.01% $154,000 4 qtrs
CITADEL ADVISORS LLC Added 155,137 +68,488 < 0.01% $144,000 5 qtrs
Virtu Financial LLC Added 140,710 +86,253 0.01% $131,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
1
Shared
0
None
1

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.